Preliminary report of a phase 2 study of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine in patients with acute myeloid leukemia.

M Baccarani; S Durrant; Werner Linkesch; K Lechner; M Cooper; S Coutre; L Leopold; B White; M Richie; M Berger

Preliminary report of a phase 2 study of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine in patients with acute myeloid leukemia.

M Baccarani
, S Durrant
, Werner Linkesch
, K Lechner
, M Cooper
, S Coutre
, L Leopold
, B White
, M Richie
, M Berger

Research output: Contribution to journal › Conference abstract

3 Citations (Web of Science)

Original language	English
Journal	Blood
Publication status	Published - 2002
Event	44th Annual Meeting of the American Society of Hematology - Philadelphia, United States Duration: 6 Dec 2002 → 10 Dec 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

302 Clinical Medicine

Cite this

@article{674d5fb34e934b21abcb5c32ef40ef96,

title = "Preliminary report of a phase 2 study of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine in patients with acute myeloid leukemia.",

author = "M Baccarani and S Durrant and Werner Linkesch and K Lechner and M Cooper and S Coutre and L Leopold and B White and M Richie and M Berger",

year = "2002",

language = "English",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

note = "44th Annual Meeting of the American Society of Hematology, ASH 44 ; Conference date: 06-12-2002 Through 10-12-2002",

}

TY - JOUR

T1 - Preliminary report of a phase 2 study of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine in patients with acute myeloid leukemia.

AU - Baccarani, M

AU - Durrant, S

AU - Linkesch, Werner

AU - Lechner, K

AU - Cooper, M

AU - Coutre, S

AU - Leopold, L

AU - White, B

AU - Richie, M

AU - Berger, M

PY - 2002

Y1 - 2002

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000179184701322

M3 - Conference abstract

SN - 0006-4971

JO - Blood

JF - Blood

T2 - 44th Annual Meeting of the American Society of Hematology

Y2 - 6 December 2002 through 10 December 2002

ER -

Preliminary report of a phase 2 study of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine in patients with acute myeloid leukemia.

UN SDGs

Branches of science

Links

Cite this